EP2726074
COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
2.7.2012:
4.4.2018:
12735408.2
:
1.7.2032
:
COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
2.7.2012
4.4.2018
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
KIM, Sunkyu:
Cambridge, Massachusetts, US
:
DOSHI, Shivang:
Cambridge, Massachusetts, US
:
HAAS, Kristy:
Cambridge, Massachusetts, US
:
KOVATS, Steven:
Cambridge, Massachusetts, US
:
HUANG, Alan Xizhong:
Cambridge, Massachusetts, US
:
CHEN, Yan:
Cambridge, Massachusetts, US
:
201161503642 P:
1.7.2011:
US
:
US2012045199:
2.7.2012
:
A61K 31/4439, A61K 31/519, A61K 31/5377, A61K 45/06, A61P 35/00